Current Status of the Six Million Dollar Man and Bionic Woman Reboots
The intellectual property rights for the Six Million Dollar Man and Bionic Woman remain managed by Universal Pictures and its parent entity, NBCUniversal, a division of Comcast. The original 1970s series, based on Martin Caidin's novel Cyborg, spawned multiple TV movies, sequels, and a short-lived 2007 NBC series. As of the latest public filings, no new series is in active production, but development rights continue to be licensed for potential feature films and streaming projects. The 2007 series, produced by David Eick and Bryan Singer, was canceled after one season despite strong initial ratings, and its rights reverted to the studio. Universal has periodically shopped the property to streaming platforms, including a reported 2023 pitch for a modernized HBO Max limited series that did not move forward. The core assets include the Cyborg narrative, the bionic technology IP, and the original character likenesses, all of which are cataloged in NBCUniversal's entertainment portfolio alongside other legacy sci-fi properties like Knight Rider and The Fall Guy.
The 2007 reboot attempted to ground the bionic technology in contemporary military ethics and corporate espionage, reflecting a shift toward darker, more realistic tone seen in contemporaneous series like Battlestar Galactica. The show starred Lee Majors reprising his role as Steve Austin, alongside a new cast including Michelle Ryan as Jaime Sommers. Despite a strong premiere drawing 16 million viewers, the series was canceled in 2008 due to high production costs and a strategic shift at NBC toward unscripted content. The failure of the reboot did not extinguish interest in the IP; instead, it demonstrated the enduring brand recognition of the Six Million Dollar Man and Bionic Woman franchises, which continue to be cited in industry analyses as valuable dormant assets. The property's valuation is tied to its global recognition, with the original series syndicated in over 40 countries and the theme song by Glen A. Larson remaining one of the most identifiable TV compositions in pop culture history.
Financial and Rights Landscape for Legacy Sci-Fi IPs
Comcast, the parent company of NBCUniversal, reported total revenue of $121.5 billion in 2023, with its Film and Streaming segment contributing a significant portion of growth. The management of legacy IPs like the Six Million Dollar Man and Bionic Woman is part of a broader strategy to monetize catalog content through licensing, streaming, and potential reboots. Industry analysts at Forbes have noted that studios increasingly view dormant TV franchises as low-risk, high-reward assets because the audience familiarity reduces marketing costs compared to original IP development. The financial model relies on optioning rights to production partners, with Universal retaining a substantial share of backend profits and merchandising revenue. The 2007 series was produced with a budget of approximately $3 million per episode, a figure that would be significantly higher today due to inflation and increased VFX costs, making a modern reboot a more capital-intensive proposition.
The rights structure for the Six Million Dollar Man and Bionic Woman is governed by the original contracts between Martin Caidin, Kenneth Johnson, and Universal Television, with subsequent amendments covering sequel and remake rights. These agreements typically include provisions for sequel participation, meaning original creators or their estates may receive a percentage of net profits from new adaptations. The legal framework is documented in SEC filings from Comcast, which detail the amortization and impairment testing of intangible assets, including entertainment properties. The valuation of such IPs is often benchmarked against comparable transactions, such as the $250 million acquisition of the Terminator rights by Skydance Media in 2023, which underscores the premium placed on iconic sci-fi franchises with built-in global audiences. The bionic technology concept has also influenced real-world robotics and prosthetics research, with companies like Boston Dynamics and